ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 21120307

Triple-negative breast carcinomas are a heterogeneous entity that differs between young and old patients.

Carvalho FM and 3 others. Clinics (Sao Paulo), 2010. Cited by 35 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Triple-negative breast carcinomas are a heterogeneous entity that differs between young and old patients. Papers, record 21120307. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21120307

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Triple-negative breast carcinomas are a heterogeneous entity that differs between young and old patients.
PubMed
Journal
Clinics (Sao Paulo)
PubMed
Year
2010
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
35
iCite
Relative citation ratio, by iCite
0.81
iCite
Revised in PubMed
2022-06-29
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Carvalho FMFilomena M
2Bacchi LMLivia M
3Santos PPPriscila P C
4Bacchi CECarlos E

Source PubMed

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
CarcinomaMajor topic
Adult
Age Factors
Chi-Square Distribution
Female
Humans
Immunohistochemistry
Keratin-5
Keratin-6
Middle Aged
Phenotype

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References27

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
116,429,394Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.J Pathol2006https://conductscience.org/library/papers/16429394PubMed
218,049,131Triple negative breast carcinoma and the basal phenotype: from expression profiling to clinical practice.Adv Anat Pathol2007https://conductscience.org/library/papers/18049131PubMed
319,907,646Breast cancer in young women: poor survival despite intensive treatment.PLoS One2009https://conductscience.org/library/papers/19907646PubMed
418,947,390The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer.BMC Cancer2008https://conductscience.org/library/papers/18947390PubMed
516,341,146Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma.Mod Pathol2006https://conductscience.org/library/papers/16341146PubMed
619,294,003Prevalence, morphologic features and proliferation indices of breast carcinoma molecular classes using immunohistochemical surrogate markers.Int J Clin Exp Pathol2009https://conductscience.org/library/papers/19294003PubMed
717,387,718
Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry.
Cancer2007https://conductscience.org/library/papers/17387718PubMed
818,682,421Expression of epidermal growth factor receptor in relation to BRCA1 status, basal-like markers and prognosis in breast cancer.J Clin Pathol2009https://conductscience.org/library/papers/18682421PubMed
918,612,148Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression.J Clin Oncol2008https://conductscience.org/library/papers/18612148PubMed
1016,857,060Effects of young age at presentation on survival in breast cancer.BMC Cancer2006https://conductscience.org/library/papers/16857060PubMed

1 to 10 of 27

See all 27 references

Cited by26

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 35 citations.

PMIDTitleJournalYearIn PapersSource
41,771,887Neoadjuvant pembrolizumab plus chemotherapy in older patients with early-stage triple-negative breast cancer: real-world insights from neo-real/GBECAM-0123.NPJ Breast Cancer2026https://conductscience.org/library/papers/41771887PubMed
38,835,377Status of breast cancer detection in young women and potential of liquid biopsy.Front Oncol2024https://conductscience.org/library/papers/38835377PubMed
37,561,981The Cholangiocarcinoma in the Young (CITY) Study: Tumor Biology, Treatment Patterns, and Survival Outcomes in Adolescent Young Adults With Cholangiocarcinoma.JCO Precis Oncol2023https://conductscience.org/library/papers/37561981PubMed
37,046,584The Association between Early-Onset Diagnosis and Clinical Outcomes in Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis.Cancers (Basel)2023https://conductscience.org/library/papers/37046584PubMed
36,687,252Is Young Age an Independent Prognostic Factor in Carcinoma Breast? A Single-Institution Retrospective Comparative Study from South India.Indian J Surg Oncol2022https://conductscience.org/library/papers/36687252PubMed
36,035,040Breast Carcinoma in Young Females: A Prospective Study in Terms of Clinicopathological Presentation at a Tertiary Care Center in India.Cureus2022https://conductscience.org/library/papers/36035040PubMed
35,569,509Plasma membrane proteoglycans syndecan-2 and syndecan-4 engage with EGFR and RON kinase to sustain carcinoma cell cycle progression.J Biol Chem2022https://conductscience.org/library/papers/35569509PubMed
35,103,812A prospective phase II clinical trial identifying the optimal regimen for carboplatin plus standard backbone of anthracycline and taxane-based chemotherapy in triple negative breast cancer.Med Oncol2022https://conductscience.org/library/papers/35103812PubMed
34,556,915Clinico-radio-pathological Features and Biological Behavior of Breast Cancer in Young Indian Women: A Prospective Study.Indian J Radiol Imaging2021https://conductscience.org/library/papers/34556915PubMed
32,856,845The TP63 Gene Polymorphism rs17506395 is Associated with Early Breast Cancer in Cameroon.Asian Pac J Cancer Prev2020https://conductscience.org/library/papers/32856845PubMed

1 to 10 of 26

See all 26 cited by

Genes16

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
BRCA1672PubTator's text mininghttps://conductscience.org/library/genes/672NCBI Gene
CMPK151,727PubTator's text mininghttps://conductscience.org/library/genes/51727NCBI Gene
EGFR1,956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
ERBB22,064PubTator's text mininghttps://conductscience.org/library/genes/2064NCBI Gene
EREG2,069PubTator's text mininghttps://conductscience.org/library/genes/2069NCBI Gene
ESR12,099PubTator's text mininghttps://conductscience.org/library/genes/2099NCBI Gene
KIT3,815PubTator's text mininghttps://conductscience.org/library/genes/3815NCBI Gene
KRT143,861PubTator's text mininghttps://conductscience.org/library/genes/3861NCBI Gene
KRT173,872PubTator's text mininghttps://conductscience.org/library/genes/3872NCBI Gene
KRT53,852PubTator's text mininghttps://conductscience.org/library/genes/3852NCBI Gene

1 to 10 of 16

See all 16 genes

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/21120307

GET https://conductscience.org/api/papers/v1/21120307/references?page=2

API referenceFor AI assistants